Oxidative stress and metabolic pathologies: From an adipocentric point of view

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Le Lay, Soazig ^a   Simard, Gilles ^a,b   Martinez, Maria Carmen ^a   Andriantsitohaina, Ramaroson ^a  

^a UNIVERSITÉ D'ANGERS   (France)

^b UNIVERSITÉ D'ANGERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; FREE RADICALS; INSULIN; METABOLISM; NUTRITION; PATHOLOGY;

CORONARY HEART DISEASE; HEPATIC STEATOSIS; INSULIN RESISTANCE; INSULIN SENSITIVITY; MECHANISTIC LINK; METABOLIC DISORDERS; REACTIVE OXYGEN SPECIES; SECOND MESSENGER;

OXIDATIVE STRESS;

2,4 THIAZOLIDINEDIONE DERIVATIVE; APELIN; OMEGA 3 FATTY ACID; POLYPHENOL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; VITAMIN; ANTIOXIDANT;

ADIPOCYTE; CALORIC RESTRICTION; CELL DIFFERENTIATION; ENDOTHELIAL DYSFUNCTION; EXERCISE; HUMAN; HYPERGLYCEMIA; HYPERLEPTINEMIA; HYPERLIPIDEMIA; INFLAMMATION; INSULIN RESPONSE; METABOLIC PARAMETERS; METABOLIC PATHOLOGY; MITOCHONDRION; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; WHITE ADIPOSE TISSUE; COMPLICATION; DRUG EFFECTS; METABOLISM;

ADIPOSE TISSUE, WHITE; ANTIOXIDANTS; HUMANS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; NADPH OXIDASE; OBESITY; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RENIN-ANGIOTENSIN SYSTEM;

EID: 84925883332     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/908539     Document Type: Review

References (192)

1. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J. M. Friedman, "Positional cloning of the mouse obese gene and its human homologue, " Nature, vol. 372, no. 6505, pp. 425-432, 1994.
2. H. Cao, "Adipocytokines in obesity and metabolic disease," Journal of Endocrinology, vol. 220, no. 2, pp. T47-T59, 2014.
3. K. L. Spalding, E. Arner, P. O. Westermark et al., "Dynamics of fat cell turnover in humans, " Nature, vol. 453, no. 7196, pp. 783-787, 2008.
4. S. P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante Jr. , "Obesity is associated with macrophage accumulation in adipose tissue, " Journal of Clinical Investigation, vol. 112, no. 12, pp. 1796-1808, 2003.
5. U. Kintscher, M. Hartge, K. Hess et al., "T-lymphocyte infiltration in visceral adipose tissue: A primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 7, pp. 1304-1310, 2008.
6. M. Qatanani and M. A. Lazar, "Mechanisms of obesityassociated insulin resistance: many choices on themenu, " Genes &Development, vol. 21, no. 12, pp. 1443-1455, 2007.
7. M. F. Gregor and G. S. Hotamisligil, "Inflammatory mechanisms in obesity, " Annual Review of Immunology, vol. 29, pp. 415-445, 2011.
8. C. K. Roberts andK. K. Sindhu, "Oxidative stress andmetabolic syndrome, " Life Sciences, vol. 84, no. 21-22, pp. 705-712, 2009.
9. H. K. Vincent and A. G. Taylor, "Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans," International Journal ofObesity, vol. 30, no. 3, pp. 400-418, 2006.
10. M. Sankhla, T. K. Sharma, K. Mathur et al., "Relationship of oxidative stress with obesity and its role in obesity induced metabolic syndrome, " Clinical Laboratory, vol. 58, no. 5-6, pp. 385-392, 2012.
11. C. Chrysohoou, D. B. Panagiotakos, C. Pitsavos et al., "The implication of obesity on total antioxidant capacity in apparently healthy men and women: the ATTICA study, " Nutrition, Metabolism & Cardiovascular Diseases, vol. 17, no. 8, pp. 590-597, 2007.
12. N. Houstis, E. D. Rosen, and E. S. Lander, "Reactive oxygen species have a causal role in multiple forms of insulin resistance," Nature, vol. 440, no. 7086, pp. 944-948, 2006.
13. T. Konrad, P. Vicini, K. Kusterer et al., "α-lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes, " Diabetes Care, vol. 22, no. 2, pp. 280-287, 1999.
14. S. Furukawa, T. Fujita, M. Shimabukuro et al., "Increased oxidative stress in obesity and its impact on metabolic syndrome," Journal of Clinical Investigation, vol. 114, no. 12, pp. 1752-1761, 2004.
15. M. P. Murphy, "How mitochondria produce reactive oxygen species, " Biochemical Journal, vol. 417, no. 1, pp. 1-13, 2009.
16. M. Brownlee, "The pathobiology of diabetic complications: a unifying mechanism, " Diabetes, vol. 54, no. 6, pp. 1615-1625, 2005.
17. K. N. Frayn, D. Langin, and F. Karpe, "Fatty acid-induced mitochondrial uncoupling in adipocytes is not a promising target for treatment of insulin resistance unless adipocyte oxidative capacity is increased, " Diabetologia, vol. 51, no. 3, pp. 394-397, 2008.
18. J. Katz and R. Rognstad, "The metabolism of tritiated glucose by rat adipose tissue, " Journal of Biological Chemistry, vol. 241, no. 15, pp. 3600-3610, 1966.
19. C. Y. Han, T. Umemoto, M. Omer et al., "NADPH oxidasederived reactive oxygen species increases expression of monocyte chemotactic factor genes in cultured adipocytes, " The Journal of Biological Chemistry, vol. 287, no. 13, pp. 10379-10393, 2012.
20. K. Bedard and K.-H. Krause, "The NOX family of ROSgeneratingNADPHoxidases: physiology and pathophysiology," Physiological Reviews, vol. 87, no. 1, pp. 245-313, 2007.
21. K. Mahadev, H. Motoshima, X. Wu et al., "The NAD(P)H oxidase homologNox4modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction," Molecular and Cellular Biology, vol. 24, no. 5, pp. 1844-1854, 2004.
22. T. Inoguchi, P. Li, F. Umeda et al., "High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells, " Diabetes, vol. 49, no. 11, pp. 1939-1945, 2000.
23. S. Dikalov, "Cross talk between mitochondria and NADPH oxidases, " Free Radical Biology and Medicine, vol. 51, no. 7, pp. 1289-1301, 2011.
24. A. E. Dikalova, A. T. Bikineyeva, K. Budzyn et al., "Therapeutic targeting of mitochondrial superoxide in hypertension, " Circulation Research, vol. 107, no. 1, pp. 106-116, 2010.
25. J. Vásquez-Vivar, B. Kalyanaraman, P. Martásek et al., "Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors, " Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 16, pp. 9220-9225, 1998.
26. N. Kuzkaya, N. Weissmann, D. G. Harrison, and S. Dikalov, "Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitricoxide synthase, The Journal of Biological Chemistry, vol. 278, no. 25, pp. 22546-22554, 2003.
27. U. Förstermann and T. Münzel, "Endothelial nitric oxide synthase in vascular disease: from marvel to menace, " Circulation, vol. 113, no. 13, pp. 1708-1714, 2006.
28. T. Heitzer, C. Brockhoff, B. Mayer et al., "Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: evidence for a dysfunctional nitric oxide synthase," Circulation Research, vol. 86, no. 2, pp. E36-E41, 2000.
29. K. Shinozaki, A. Kashiwagi, Y. Nishio et al., "Abnormal biopterin metabolism is a major cause of impaired endotheliumdependent relaxation through nitric oxide/O2-imbalance in insulin-resistant rat aorta, " Diabetes, vol. 48, no. 12, pp. 2437-2445, 1999.
30. M. Perreault and A. Marette, "Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle, " Nature Medicine, vol. 7, no. 10, pp. 1138-1143, 2001.
31. M. Elizalde, M. Rydén, V. Van Harmelen et al., "Expression of nitric oxide synthases in subcutaneous adipose tissue of nonobese and obese humans, " Journal of Lipid Research, vol. 41, no. 8, pp. 1244-1251, 2000.
32. S. Engeli, J. Janke, K. Gorzelniak et al., "Regulation of the nitric oxide system in human adipose tissue, " Journal of Lipid Research, vol. 45, no. 9, pp. 1640-1648, 2004.
33. J. M. Curtis, P. A. Grimsrud, W. S. Wright et al., "Downregulation of adipose glutathione S-tansferase A4 leads to increased protein carbonylation, oxidative stress, and mitochondrial dysfunction," Diabetes, vol. 59, no. 5, pp. 1132-1142, 2010.
34. I. Talior, T. Tennenbaum, T. Kuroki, and H. Eldar-Finkelman, "PKC-δ-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice: Role for NADPH oxidase," American Journal of Physiology: Endocrinology andMetabolism, vol. 288, no. 2, pp. E405-E411, 2005.
35. Y. Lin, A. H. Berg, P. Iyengar et al., "The hyperglycemiainduced inflammatory response in adipocytes: the role of reactive oxygen species, " Journal of Biological Chemistry, vol. 280, no. 6, pp. 4617-4626, 2005.
36. H. Lee, Y. J. Lee, H. Choi, E. H. Ko, and J. Kim, "Reactive oxygen species facilitate adipocyte differentiation by accelerating mitotic clonal expansion, " The Journal of Biological Chemistry, vol. 284, no. 16, pp. 10601-10609, 2009.
37. C.-L. Gao, C. Zhu, Y.-P. Zhao et al., "Mitochondrial dysfunction is induced by high levels of glucose and free fatty acids in 3T3-L1 adipocytes, " Molecular and Cellular Endocrinology, vol. 320, no. 1-2, pp. 25-33, 2010.
38. C. Y. Han, A. Y. Kargi, M. Omer et al., "Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: dissociation of adipocyte hypertrophy from inflammation," Diabetes, vol. 59, no. 2, pp. 386-396, 2010.
39. A. De Pauw, S. Tejerina, M. Raes, J. Keijer, and T. Arnould, "Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations, American Journal of Pathology, vol. 175, no. 3, pp. 927-939, 2009.
40. V. Visentin, D. Prévot, V. D. De Saint Front et al., "Alteration of amine oxidase activity in the adipose tissue of obese subjects," Obesity Research, vol. 12, no. 3, pp. 547-555, 2004.
41. A. Galinier, A. Carriere, Y. Fernandez et al., "Adipose tissue proadipogenic redox changes in obesity, " The Journal of Biological Chemistry, vol. 281, no. 18, pp. 12682-12687, 2006.
42. A. Galinier, A. Carriere, Y. Fernandez et al., "Site specific changes of redox metabolism in adipose tissue of obese Zucker rats, " FEBS Letters, vol. 580, no. 27, pp. 6391-6398, 2006.
43. J.-F. Landrier, J. Marcotorchino, and F. Tourniaire, "Lipophilic micronutrients and adipose tissue biology, " Nutrients, vol. 4, no. 11, pp. 1622-1649, 2012.
44. T. Kuno, M. Hozumi, T. Morinobu, T. Murata, Z. Mingci, and H. Tamai, "Antioxidant vitamin levels in plasma and lowdensity lipoprotein of obese girls, " Free Radical Research, vol. 28, no. 1, pp. 81-86, 1998.
45. M. L. Neuhouser, C. L. Rock, A. L. Eldridge et al., "Serum concentrations of retinol, α-tocopherol and the carotenoids are influenced by diet, race and obesity in a sample of healthy adolescents, " Journal of Nutrition, vol. 131, no. 8, pp. 2184-2191, 2001.
46. M. Blum, G. Dolnikowski, E. Seyoum et al., "Vitamin D 3 in fat tissue, " Endocrine, vol. 33, no. 1, pp. 90-94, 2008.
47. R. S. Parker, "Carotenoids in human blood and tissues, " Journal of Nutrition, vol. 119, no. 1, pp. 101-104, 1989.
48. M. G. Traber and H. J. Kayden, "Tocopherol distribution and intracellular localization in human adipose tissue, " American Journal of Clinical Nutrition, vol. 46, no. 3, pp. 488-495, 1987.
49. B. DAutréaux and M. B. Toledano, "ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis," Nature ReviewsMolecular Cell Biology, vol. 8, no. 10, pp. 813-824, 2007.
50. M. Ristow and S. Schmeisser, "Extending life span by increasing oxidative stress, " Free Radical Biology and Medicine, vol. 51, no. 2, pp. 327-336, 2011.
51. L. Mao and J. Franke, "Hormesis in aging and neurodegeneration-a prodigy awaiting dissection, " International Journal of Molecular Sciences, vol. 14, no. 7, pp. 13109-13128, 2013.
52. S. Desaint, S. Luriau, J. Aude, G. Rousselet, and M. B. Toledano, "Mammalian antioxidant defenses are not inducible by H2O2," The Journal of Biological Chemistry, vol. 279, no. 30, pp. 31157-31163, 2004.
53. E. Abuin, E. Lissi, and M. Ahumada, "Diffusion of hydrogen peroxide across DPPC large unilamellar liposomes, " Chemistry and Physics of Lipids, vol. 165, no. 6, pp. 656-661, 2012.
54. R. M. Cordeiro, "Reactive oxygen species at phospholipid bilayers: distribution, mobility and permeation, " Biochimica et Biophysica Acta, vol. 1838, no. 1, part B, pp. 438-444, 2014.
55. J. M. May and C. De Haen, "Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal fat cells," Journal of Biological Chemistry, vol. 254, no. 7, pp. 2214-2220, 1979.
56. H. I. Krieger-Brauer, P. K. Medda, and H. Kather, "Insulininduced activation of NADPH-dependent H2O2 generation in human adipocyte plasma membranes is mediated by Gα(i2)," Journal of Biological Chemistry, vol. 272, no. 15, pp. 10135-10143, 1997.
57. M. P. Czech, J. C. Lawrence Jr. , and W. S. Lynn, "Evidence for the involvement of sulfhydryl oxidation in the regulation of fat cell hexose transport by insulin, " Proceedings of the National Academy of Sciences of the United States of America, vol. 71, no. 10, pp. 4173-4177, 1974.
58. G. R. Hayes and D. H. Lockwood, "Role of insulin receptor phosphorylation in the insulinomimetic effects of hydrogen peroxide, " Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 22, pp. 8115-8119, 1987.
59. T. Kono, F. W. Robinson, T. L. Blevins, and O. Ezaki, "Evidence that translocation of the glucose transport activity is the major mechanism of insulin action on glucose transport in fat cells," Journal of Biological Chemistry, vol. 257, no. 18, pp. 10942-10947, 1982.
60. S. A. Little and C. de Haen, "Effects of hydrogen peroxide on basal and hormone-stimulated lipolysis in perifused rat fat cells in relation to the mechanism of action of insulin, " Journal of Biological Chemistry, vol. 255, no. 22, pp. 10888-10895, 1980.
61. K. Mahadev, X. Wu, A. Zilbering, L. Zhu, J. T. R. Lawrence, and B. J. Goldstein, "Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes, " The Journal of Biological Chemistry, vol. 276, no. 52, pp. 48662-48669, 2001.
62. K. Loh, H. Deng, A. Fukushima et al., "Reactive oxygen species enhance insulin sensitivity, " Cell Metabolism, vol. 10, no. 4, pp. 260-272, 2009.
63. A. Rudich, N. Kozlovsky, R. Potashnik, and N. Bashan, "Oxidant stress reduces insulin responsiveness in 3T3-L1 adipocytes," American Journal of Physiology: Endocrinology andMetabolism, vol. 272, no. 5, pp. E935-E940, 1997.
64. C. H. Wang, H. Huang, and Y. Wei, "Mitochondrial dysfunction leads to impairment of insulin sensitivity and adiponectin secretion in adipocytes, " FEBS Journal, vol. 280, no. 4, pp. 1039-1050, 2013.
65. E. J. Anderson, M. E. Lustig, K. E. Boyle et al., "Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans, " Journal of Clinical Investigation, vol. 119, no. 3, pp. 573-581, 2009.
66. G. Murdolo, M. Piroddi, F. Luchetti et al., "Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation and obesity-linked insulin resistance," Biochimie, vol. 95, no. 3, pp. 585-594, 2013.
67. A. P. Russell, G. Gastaldi, E. Bobbioni-Harsch et al., "Lipid peroxidation in skeletalmuscle of obese as compared to endurancetrained humans: a case of good vs. bad lipidsØ FEBS Letters, vol. 551, no. 1-3, pp. 104-106, 2003.
68. K. H. Ingram, H. Hill, D. R. Moellering et al., "Skeletalmuscle lipid peroxidation and insulin resistance in humans, " The Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 7, pp. E1182-E1186, 2012.
69. N. J. Pillon, M. L. Croze, R. E. Vella, L. Soulere, M. Lagarde, and C. O. Soulage, "The lipid peroxidation by-product 4-hydroxy-2-nonenal (4-HNE) induces insulin resistance in skeletal muscle through both carbonyl and oxidative stress, " Endocrinology, vol. 153, no. 5, pp. 2099-2111, 2012.
70. I. Miwa, N. Ichimura, M. Sugiura, Y. Hamada, and S. Taniguchi, "Inhibition of glucose-induced insulin secretion by 4-hydroxy-2-nonenal and other lipid peroxidation products, " Endocrinology, vol. 141, no. 8, pp. 2767-2772, 2000.
71. D. Demozay, J. Mas, S. Rocchi, and E. VanObberghen, "FALDH reverses the deleterious action of oxidative stress induced by lipid peroxidation product 4-hydroxynonenal on insulin signaling in 3T3-L1 adipocytes, " Diabetes, vol. 57, no. 5, pp. 1216-1226, 2008.
72. A. F. Soares, M. Guichardant, D. Cozzone et al., "Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes, " Free Radical Biology and Medicine, vol. 38, no. 7, pp. 882-889, 2005.
73. P. A. Grimsrud, M. J. Picklo Sr. , T. J. Griffin, and D. A. Bernlohr, "Carbonylation of adipose proteins in obesity and insulin resistance: Identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal, Molecular and Cellular Proteomics, vol. 6, no. 4, pp. 624-637, 2007.
74. X. Zhang, Z. Wang, J. Li et al., "Increased 4-hydroxynonenal formation contributes to obesity-related lipolytic activation in adipocytes, " PLoS ONE, vol. 8, no. 8, Article ID e70663, 2013.
75. B. Zarrouki, A. F. Soares, M. Guichardant, M. Lagarde, and A. Gélo?n, "The lipid peroxidation end-product 4-HNE induces COX-2 expression through p38MAPK activation in 3T3-L1 adipose cell, " FEBS Letters, vol. 581, no. 13, pp. 2394-2400, 2007.
76. R. Ye and P. E. Scherer, "Adiponectin, driver or passenger on the road to insulin sensitivityØ Molecular Metabolism, vol. 2, no. 3, pp. 133-141, 2013.
77. K. Fujita, H. Nishizawa, T. Funahashi, I. Shimomura, and M. Shimabukuro, "Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome, " Circulation Journal, vol. 70, no. 11, pp. 1437-1442, 2006.
78. L. Tao, E. Gao, X. Jiao et al., "Adiponectin cardioprotection aftermyocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress, " Circulation, vol. 115, no. 11, pp. 1408-1416, 2007.
79. R. Li, W.-Q. Wang, H. Zhang et al., "Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity, " American Journal of Physiology: Endocrinology and Metabolism, vol. 293, no. 6, pp. E1703-E1708, 2007.
80. K. Schröder, K. Wandzioch, I. Helmcke, and R. P. Brandes, "Nox4 acts as a switch between differentiation and proliferation in preadipocytes, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 2, pp. 239-245, 2009.
81. M. Higuchi, G. J. Dusting, H. Peshavariya et al., "Differentiation of human adipose-derived stem cells into fat involves reactive oxygen species and forkhead box o1 mediated upregulation of antioxidant enzymes, " Stem Cells and Development, vol. 22, no. 6, pp. 878-888, 2013.
82. Y. Kanda, T. Hinata, S. W. Kang, and Y. Watanabe, "Reactive oxygen species mediate adipocyte differentiation in mesenchymal stem cells, " Life Sciences, vol. 89, no. 7-8, pp. 250-258, 2011.
83. K. V. Tormos, E. Anso, R. B. Hamanaka et al., "Mitochondrial complex III ROS regulate adipocyte differentiation, " Cell Metabolism, vol. 14, no. 4, pp. 537-544, 2011.
84. A. Carriere, M. Carmona, Y. Fernandez et al., "Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: a mechanism for hypoxia-dependent effect, " Journal of Biological Chemistry, vol. 279, no. 39, pp. 40462-40469, 2004.
85. A. Vidal-Puig, "Adipose tissue expandability, lipotoxicity and the metabolic syndrome, " Endocrinologia y Nutricion, vol. 60, no. 1, pp. 39-43, 2013.
86. J. S. Stern, B. R. Batchelor, N. Hollander, C. K. Cohn, and J. Hirsch, "Adipose-cell size and immunoreactive insulin levels in obese and normal-weight adults. , " The Lancet, vol. 2, no. 7784, pp. 948-951, 1972.
87. M. Lundgren, M. Svensson, S. Lindmark, F. Renström, T. Ruge, and J. W. Eriksson, "Fat cell enlargement is an independent marker of insulin resistance and hyperleptinaemia, " Diabetologia, vol. 50, no. 3, pp. 625-633, 2007.
88. T. Volk, M. Hensel, H. Schuster, and W. J. Kox, "Secretion of MCP-1 and IL-6 by cytokine stimulated production of reactive oxygen species in endothelial cells, " Molecular and Cellular Biochemistry, vol. 206, no. 1-2, pp. 105-112, 2000.
89. N. S. Chandel, P. T. Schumacker, and R. H. Arch, "Reactive oxygen species are downstream products of TRAF-mediated signal transduction, " Journal of Biological Chemistry, vol. 276, no. 46, pp. 42728-42736, 2001.
90. B. I. Frohnert, E. K. Long, W. S. Hahn, and D. A. Bernlohr, "Glutathionylated lipid aldehydes are products of adipocyte oxidative stress and activators of macrophage inflammation," Diabetes, vol. 63, no. 1, pp. 89-100, 2013.
91. E. K. Long, D. M. Olson, and D. A. Bernlohr, "High-fat diet induces changes in adipose tissue trans-4-oxo-2-nonenal and trans-4-hydroxy-2-nonenal levels in a depot-specific manner," Free Radical Biology and Medicine, vol. 63, pp. 390-398, 2013.
92. Y. Zhang and X. Chen, "Reducing selenoprotein P expression suppresses adipocyte differentiation as a result of increased preadipocyte inflammation, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 300, no. 1, pp. E77-E85, 2011.
93. H. Jay Forman and M. Torres, "Redox signaling in macrophages," Molecular Aspects ofMedicine, vol. 22, no. 4-5, pp. 189-216, 2001.
94. C. N. Lumeng, J. L. Bodzin, and A. R. Saltiel, "Obesity induces a phenotypic switch in adipose tissue macrophage polarization," Journal of Clinical Investigation, vol. 117, no. 1, pp. 175-184, 2007.
95. D. C. Dale, L. Boxer, and W. Conrad Liles, "The phagocytes: neutrophils and monocytes, " Blood, vol. 112, no. 4, pp. 935-945, 2008.
96. M. Löhn, G. Dubrovska, B. Lauterbach, F. C. Luft, M. Gollasch, and A. M. Sharma, "Periadventitial fat releases a vascular relaxing factor, " FASEB Journal, vol. 16, no. 9, pp. 1057-1063, 2002.
97. G. A. Payne, H. G. Bohlen, ØU. D. Dincer, L. Borbouse, and J. D. Tune, "Periadventitial adipose tissue impairs coronary endothelial function via PKC-β-dependent phosphorylation of nitric oxide synthase, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 297, no. 1, pp. H460-H465, 2009.
98. J. Ketonen, J. Shi, E. Martonen, and E. Mervaala, "Periadventitial adipose tissue promotes endothelial dysfunction via oxidative stress in diet-induced obese C57BL/6 mice, " Circulation Journal, vol. 74, no. 7, pp. 1479-1487, 2010.
99. N. Hosogai, A. Fukuhara, K. Oshima et al., "Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation," Diabetes, vol. 56, no. 4, pp. 901-911, 2007.
100. J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky, "Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunctionØ Diabetes, vol. 52, no. 1, pp. 1-8, 2003.
101. T. L. Archuleta, A. M. Lemieux, V. Saengsirisuwan et al., "Oxidant stress-induced loss of IRS-1 and IRS-2 proteins in rat skeletal muscle: role of p38 MAPK, " Free Radical Biology and Medicine, vol. 47, no. 10, pp. 1486-1493, 2009.
102. H. Kaneto, Y. Nakatani, D. Kawamori, T. Miyatsuka, and T. Matsuoka, "Involvement of oxidative stress and the JNK pathway in glucose toxicity, " The Review of Diabetic Studies, vol. 1, no. 4, pp. 165-174, 2004.
103. M. C. Arkan, A. L. Hevener, F. R. Greten et al., "IKK-β links inflammation to obesity-induced insulin resistance, " Nature Medicine, vol. 11, no. 2, pp. 191-198, 2005.
104. J. Hirosumi, G. Tuncman, L. Chang et al., "A central, role for JNK inobesity and insulinresistance, " Nature, vol. 420, no. 6913, pp. 333-336, 2002.
105. J. F. Keaney Jr. , M. G. Larson, R. S. Vasan et al., "Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham study, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 3, pp. 434-439, 2003.
106. J. Szendroedi, E. Phielix, and M. Roden, "The role of mitochondria in insulin resistance and type 2 diabetes mellitus, " Nature Reviews Endocrinology, vol. 8, no. 2, pp. 92-103, 2012.
107. C. Wang and Y. Wei, "Mitochondrial dysfunction in insulin insensitivity: implication of mitochondrial role in type 2 diabetes," Annals of the New York Academy of Sciences, vol. 1201, pp. 157-165, 2010.
108. The Diabetes Control and Complications Trial Research Group, "The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus, " The New England Journal of Medicine, vol. 329, no. 14, pp. 977-986, 1993.
109. X. Du, T. Matsumura, D. Edelstein et al., "Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells, " The Journal of Clinical Investigation, vol. 112, no. 7, pp. 1049-1057, 2003.
110. K. H. Gabbay, L. O. Merola, and R. A. Field, "Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes, " Science, vol. 151, no. 3707, pp. 209-210, 1966.
111. X. L. Du, D. Edelstein, S. Dimmeler, Q. Ju, C. Sui, and M. Brownlee, "Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site, " Journal of Clinical Investigation, vol. 108, no. 9, pp. 1341-1348, 2001.
112. A. Bierhaus, M. A. Hofmann, R. Ziegler, and P. P. Nawroth, "AGEs and their interaction withAGE-receptors in vascular disease and diabetesmellitus. I. The AGE concept, " Cardiovascular Research, vol. 37, no. 3, pp. 586-600, 1998.
113. T. S. Lee, K. A. Saltsman, H. Ohashi, and G. L. King, "Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications, " Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 13, pp. 5141-5145, 1989.
114. P. Geraldes and G. L. King, "Activation of protein kinase C isoforms and its impact on diabetic complications, " Circulation Research, vol. 106, no. 8, pp. 1319-1331, 2010.
115. H. Ishii, M. R. Jirousek, D. Koya et al., "Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor," Science, vol. 272, no. 5262, pp. 728-731, 1996.
116. T. Nishikawa, D. Edelstein, X. L. Du et al., "Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage, " Nature, vol. 404, no. 6779, pp. 787-790, 2000.
117. B. Lu, D. Ennis, R. Lai et al., "Enhanced sensitivity of insulinresistant adipocytes to vanadate is associated with oxidative stress and decreased reduction of vanadate (+5) to vanadyl (+4), " Journal of Biological Chemistry, vol. 276, no. 38, pp. 35589-35598, 2001.
118. S. Tang, H. Le-Tien, B. J. Goldstein, P. Shin, R. Lai, and I. G. Fantus, "Decreased in situ insulin receptor dephosphorylation in hyperglycemia-induced insulin resistance in rat adipocytes," Diabetes, vol. 50, no. 1, pp. 83-90, 2001.
119. T. B. Koenen, R. Stienstra, L. J. van Tits et al., "Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1β transcription in human adipose tissue, " Diabetes, vol. 60, no. 2, pp. 517-524, 2011.
120. P. Björntorp, H. Bergman, and E. Varnauskas, "Plasma free fatty acid turnover rate in obesity, " Acta Medica Scandinavica, vol. 185, no. 4, pp. 351-356, 1969.
121. M. D. Jensen, M. W. Haymond, R. A. Rizza, P. E. Cryer, and J. M. Miles, "Influence of body fat distribution on free fatty acid metabolism in obesity, " Journal of Clinical Investigation, vol. 83, no. 4, pp. 1168-1173, 1989.
122. G. Paolisso, G. Di Maro, G. Pizza et al., "Plasma GSH/GSSG affects glucose homeostasis in healthy subjects and noninsulin-dependent diabetics, " American Journal of Physiology: Endocrinology andMetabolism, vol. 263, no. 3, part 2, pp. E435-E440, 1992.
123. L. Wojtczak and P. Schonfeld, "Effect of fatty acids on energy coupling processes in mitochondria, " Biochimica et Biophysica Acta-Bioenergetics, vol. 1183, no. 1, pp. 41-57, 1993.
124. L. F. van Gaal, J. Vertommen, and I. H. de Leeuw, "The in vitro oxidizability of lipoprotein particles in obese and nonobese subjects, " Atherosclerosis, vol. 137, supplement, pp. S39-S44, 1998.
125. A. Bouloumié, T. Marumo, M. Lafontan, and R. Busse, "Leptin induces oxidative stress in human endothelial cells, " FASEB Journal, vol. 13, no. 10, pp. 1231-1238, 1999.
126. S. Yamagishi, D. Edelstein, X. Du, Y. Kaneda, M. Guzmán, and M. Brownlee, "Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A, " The Journal of Biological Chemistry, vol. 276, no. 27, pp. 25096-25100, 2001.
127. L. Li, J. Mamputu, N. Wiernsperger, and G. Renier, "Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin, " Diabetes, vol. 54, no. 7, pp. 2227-2234, 2005.
128. F. Maingrette and G. Renier, "Leptin increases lipoprotein lipase secretion by macrophages: involvement of oxidative stress and protein kinase C, " Diabetes, vol. 52, no. 8, pp. 2121-2128, 2003.
129. J. Be?towski, G. Wójcicka, and A. Jamroz, "Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress:The possible novel mechanism for proatherogenic effect of chronic hyperleptinemia, " Atherosclerosis, vol. 170, no. 1, pp. 21-29, 2003.
130. L. A. Cassis, S. B. Police, F. Yiannikouris, and S. E. Thatcher, "Local adipose tissue renin-angiotensin system, CurrentHypertension Reports, vol. 10, no. 2, pp. 93-98, 2008.
131. S. Engeli, P. Schling, K. Gorzelniak et al., "The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndromeØ International Journal of Biochemistry and Cell Biology, vol. 35, no. 6, pp. 807-825, 2003.
132. K. K. Griendling, C. A. Minieri, J. D. Ollerenshaw, and R. W. Alexander, "Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells," Circulation Research, vol. 74, no. 6, pp. 1141-1148, 1994.
133. R. P. Brandes and J. Kreuzer, "Vascular NADPH oxidases: molecular mechanisms of activation, " Cardiovascular Research, vol. 65, no. 1, pp. 16-27, 2005.
134. A. Kurata, H. Nishizawa, S. Kihara et al., "Blockade of angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation," Kidney International, vol. 70, no. 10, pp. 1717-1724, 2006.
135. P. Dandona, P. Mohanty, H. Ghanim et al., "The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation, The Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 1, pp. 355-362, 2001.
136. A. B. Crujeiras, D. Parra, F. I. Milagro et al., "Differential expression of oxidative stress and inflammation related genes in peripheral blood mononuclear cells in response to a low-calorie diet: a nutrigenomics study, " OMICS, vol. 12, no. 4, pp. 251-261, 2008.
137. C. Cantó and J. Auwerx, "Targeting sirtuin 1 to improve metabolism: All you need is NAD+Ø Pharmacological Reviews, vol. 64, no. 1, pp. 166-187, 2012.
138. V. Perrot and M. M. Rechler, "Characterization of insulin inhibition of transactivation by a C-terminal fragment of the forkhead transcription factor Foxo1 in rat hepatoma cells, " The Journal of Biological Chemistry, vol. 278, no. 28, pp. 26111-26119, 2003.
139. A. Brunet, L. B. Sweeney, J. F. Sturgill et al., "Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase," Science, vol. 303, no. 5666, pp. 2011-2015, 2004.
140. D. R. Calnan and A. Brunet, "The FoxO code, " Oncogene, vol. 27, no. 16, pp. 2276-2288, 2008.
141. G. López-Lluch, N. Hunt, B. Jones et al., "Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 6, pp. 1768-1773, 2006.
142. M.-C. Gomez-Cabrera, E. Domenech, and J. Viña, "Moderate exercise is an antioxidant: upregulation of antioxidant genes by training, " Free Radical Biology and Medicine, vol. 44, no. 2, pp. 126-131, 2008.
143. N. G. Boulé, S. J. Weisnagel, T. A. Lakka et al., "Effects of exercise training on glucose homeostasis: the HERITAGE family study," Diabetes Care, vol. 28, no. 1, pp. 108-114, 2005.
144. F. G. S. Toledo, E. V. Menshikova, V. B. Ritov et al., "Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes," Diabetes, vol. 56, no. 8, pp. 2142-2147, 2007.
145. B. Balkau, L. Mhamdi, J. Oppert et al., "Physical activity and insulin sensitivity the RISC study, " Diabetes, vol. 57, no. 10, pp. 2613-2618, 2008.
146. P. M. Kris-Etherton, W. S. Harris, and L. J. Appel, "Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 2, pp. 151-152, 2003.
147. P. C. Calder, "n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases, " The American Journal of Clinical Nutrition, vol. 83, no. 6, 2006.
148. A. González-Périz, R. Horrillo, N. Ferré et al., "Obesity-induced insulin resistance and hepatic steatosis are alleviated by w-3 fatty acids: A role for resolvins and protectins, " The FASEB Journal, vol. 23, no. 6, pp. 1946-1957, 2009.
149. C. Fan, H. Zirpoli, and K. Qi, "N-3 fatty acids modulate adipose tissue inflammation and oxidative stress, " Current Opinion in Clinical Nutrition andMetabolic Care, vol. 16, no. 2, pp. 124-132, 2013.
150. S. Schmidt, F. Stahl, K. Mutz, T. Scheper, A. Hahn, and J. P. Schuchardt, "Transcriptome-based identification of antioxidative gene expression after fish oil supplementation in normoand dyslipidemic men, " Nutrition and Metabolism, vol. 9, no. 1, article 45, 2012.
151. C. Kusunoki, L. Yang, T. Yoshizaki et al., "Omega-3 polyunsaturated fatty acid has an anti-oxidant effect via the Nrf-2/HO-1 pathway in 3T3-L1 adipocytes, " Biochemical and Biophysical Research Communications, vol. 430, no. 1, pp. 225-230, 2013.
152. M. Spencer, B. S. Finlin, R. Unal et al., "Omega-3 fatty acids reduce adipose tissue macrophages in human subjects with insulin resistance, " Diabetes, vol. 62, no. 5, pp. 1709-1717, 2013.
153. A. Moor De Burgos, M. Wartanowicz, and S. Ziemlariski, "Blood vitamin and lipid levels in overweight and obese women, " European Journal of Clinical Nutrition, vol. 46, no. 11, pp. 803-808, 1992.
154. R. S. Strauss, "Comparison of serum concentrations of α-tocopherol and β-carotene in a cross-sectional sample of obese and nonobese children (NHANES III), " Journal of Pediatrics, vol. 134, no. 2, pp. 160-165, 1999.
155. A. Esfahani, J. M. W. Wong, J. Truan et al., "Health effects of mixed fruit and vegetable concentrates: a systematic review of the clinical interventions, " Journal of the American College of Nutrition, vol. 30, no. 5, pp. 285-294, 2011.
156. I. Savini, M. V. Catani, D. Evangelista, V. Gasperi, and L. Avigliano, "Obesity-associated oxidative stress: strategies finalized to improve redox state, " International Journal of Molecular Sciences, vol. 14, no. 5, pp. 10497-10538, 2013.
157. G. Bjelakovic, D. Nikolova, L. L. Gluud, R. G. Simonetti, and C. Gluud, "Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis, " The Journal of the AmericanMedical Association, vol. 297, no. 8, pp. 842-857, 2007.
158. G. Bjelakovic, A. Nagorni, D. Nikolova, R. G. Simonetti, M. Bjelakovic, and C. Gluud, "Meta-analysis: Antioxidant supplements for primary and secondary prevention of colorectal adenoma, " Alimentary Pharmacology andTherapeutics, vol. 24, no. 2, pp. 281-291, 2006.
159. P. T. Schumacker, "Reactive oxygen species in cancer cells: live by the sword, die by the sword, " Cancer Cell, vol. 10, no. 3, pp. 175-176, 2006.
160. R. Andriantsitohaina, L. Duluc, J. C. Garciá-Rodrieuez et al., "Systems biology of antioxidants, " Clinical Science, vol. 123, no. 3, pp. 173-192, 2012.
161. R. Andriantsitohaina, C. Auger, T. Chataigneau et al., "Molecular mechanisms of the cardiovascular protective effects of polyphenols, The British Journal of Nutrition, vol. 108, no. 9, pp. 1532-1549, 2012.
162. A. Agouni, A. Lagrue-Lak-Hal, H. A. Mostefai et al., "Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in Zucker fatty rats (Fa/Fa), " PLoS ONE, vol. 4, no. 5, Article ID e5557, 2009.
163. J. A. Baur, K. J. Pearson, N. L. Price et al., "Resveratrol improves health and survival of mice on a high-calorie diet, " Nature, vol. 444, no. 7117, pp. 337-342, 2006.
164. L. Rivera, R. Morón, A. Zarzuelo, and M. Galisteo, "Longtermresveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats, " Biochemical Pharmacology, vol. 77, no. 6, pp. 1053-1063, 2009.
165. L. Rivera, R. Morón, M. Sánchez, A. Zarzuelo, and M. Galisteo, "Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats, " Obesity, vol. 16, no. 9, pp. 2081-2087, 2008.
166. S. Wang, N. Moustaid-Moussa, L. Chen et al., "Novel insights of dietary polyphenols and obesity, " The Journal of Nutritional Biochemistry, vol. 25, no. 1, pp. 1-18, 2014.
167. S. Hatia, A. Septembre-Malaterre, F. Le Sage et al., "Evaluation of antioxidant properties ofmajor dietary polyphenols and their protective effect on 3T3-L1 preadipocytes and red blood cells exposed to oxidative stress, " Free Radical Research, vol. 48, no. 4, pp. 387-401, 2014.
168. A. Ejaz, D. Wu, P. Kwan, and M. Meydani, "Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice, " Journal ofNutrition, vol. 139, no. 5, pp. 919-925, 2009.
169. P. Fischer-Posovszky, V. Kukulus, D. Tews et al., "Resveratrol regulates human adipocyte number and function in a Sirt1-dependentmanner, The American Journal of Clinical Nutrition, vol. 92, no. 1, pp. 5-15, 2010.
170. H.-J. Park, U. J. Jung, M.-K. Lee et al., "Modulation of lipid metabolism by polyphenol-rich grape skin extract improves liver steatosis and adiposity in high fat fed mice, " Molecular Nutrition & Food Research, vol. 57, no. 2, pp. 360-364, 2013.
171. C. Tian, X. Ye, R. Zhang et al., "Green Tea Polyphenols Reduced Fat Deposits in High Fat-Fed Rats via erk1/2-PPARγ-Adiponectin Pathway, " PLoS ONE, vol. 8, no. 1, Article ID e53796, 2013.
172. S. Uchiyama, Y. Taniguchi, A. Saka, A. Yoshida, and H. Yajima, "Prevention of diet-induced obesity by dietary black tea polyphenols extract in vitro and in vivo, " Nutrition, vol. 27, no. 3, pp. 287-292, 2011.
173. P. J. Turnbaugh, R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis, and J. I. Gordon, "An obesity-associated gut microbiomewith increased capacity for energy harvest, " Nature, vol. 444, no. 7122, pp. 1027-1031, 2006.
174. V. K. Ridaura, J. J. Faith, F. E. Rey et al., "Gutmicrobiota from twins discordant for obesity modulate metabolism in mice," Science, vol. 341, no. 6150, Article ID 1241214, 2013.
175. S. Bolca, T. van deWiele, and S. Possemiers, "Gut metabotypes govern health effects of dietary polyphenols, " Current Opinion in Biotechnology, vol. 24, no. 2, pp. 220-225, 2013.
176. M. Ahmadian, J. M. Suh, N. Hah et al., "PPARγ signaling and metabolism: the good, the bad and the future, " Nature Medicine, vol. 19, no. 5, pp. 557-566, 2013.
177. L. Wilson-Fritch, A. Burkart, G. Bell et al., "Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone, " Molecular and Cellular Biology, vol. 23, no. 3, pp. 1085-1094, 2003.
178. L. Wilson-Fritch, S. Nicoloro, M. Chouinard et al., "Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone, " The Journal of Clinical Investigation, vol. 114, no. 9, pp. 1281-1289, 2004.
179. H. Ohno, K. Shinoda, B. M. Spiegelman, and S. Kajimura, "PPARγ agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein, " CellMetabolism, vol. 15, no. 3, pp. 395-404, 2012.
180. L. Qiang, L. Wang, N. Kon et al., "Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ, " Cell, vol. 150, no. 3, pp. 620-632, 2012.
181. J. Boucher, B. Masri, D. Daviaud et al., "Apelin, a newly identified adipokine up-regulated by insulin and obesity," Endocrinology, vol. 146, no. 4, pp. 1764-1771, 2005.
182. C. Dray, C. Knauf, D. Daviaud et al., "Apelin stimulates glucose utilization in normal and obese insulin-resistant mice, " Cell Metabolism, vol. 8, no. 5, pp. 437-445, 2008.
183. P. Yue, H. Jin, S. Xu et al., "Apelin decreases lipolysis viaGq, Gi, and AMPK-dependent mechanisms, " Endocrinology, vol. 152, no. 1, pp. 59-68, 2011.
184. A. Than, Y. Cheng, L. Foh et al., "Apelin inhibits adipogenesis and lipolysis through distinct molecular pathways, " Molecular and Cellular Endocrinology, vol. 362, no. 1-2, pp. 227-241, 2012.
185. C. Foussal, O. Lairez, D. Calise et al., "Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy," FEBS Letters, vol. 584, no. 11, pp. 2363-2370, 2010.
186. H. J. Chun, Z. A. Ali, Y. Kojima et al., "Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis," The Journal of Clinical Investigation, vol. 118, no. 10, pp. 3343-3354, 2008.
187. X. J. Zeng, S. P. Yu, L. Zhang, and L. Wei, "Neuroprotective effect of the endogenous neural peptide apelin in cultured mouse cortical neurons, " Experimental Cell Research, vol. 316, no. 11, pp. 1773-1783, 2010.
188. W. Hung, T. Hsieh, T. Lin et al., "Blockade of the reninangiotensin system ameliorates apelin production in 3T3-L1 adipocytes, " Cardiovascular Drugs and Therapy, vol. 25, no. 1, pp. 3-12, 2011.
189. C. Vickers, P. Hales, V. Kaushik et al., "Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase," Journal of Biological Chemistry, vol. 277, no. 17, pp. 14838-14843, 2002.
190. S. Lorente-Cebrián, M. Bustos, A. Marti, J. A. Martinez, and M. J. Moreno-Aliaga, "Eicosapentaenoic acid up-regulates apelin secretion and gene expression in 3T3-L1 adipocytes, " Molecular Nutrition and Food Research, vol. 54, no. 1, pp. S104-S111, 2010.
191. X. Iturrioz, R. Alvear-Perez, N. de Mota et al., "Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonist, " The FASEB Journal, vol. 24, no. 5, pp. 1506-1517, 2010.
192. F. Addabbo, M. Montagnani, and M. S. Goligorsky, "Mitochondria and reactive oxygen species, " Hypertension, vol. 53, no. 6, pp. 885-892, 2009.